DE3687145D1 - Anorganische mineralzusammensetzung. - Google Patents

Anorganische mineralzusammensetzung.

Info

Publication number
DE3687145D1
DE3687145D1 DE8686301421T DE3687145T DE3687145D1 DE 3687145 D1 DE3687145 D1 DE 3687145D1 DE 8686301421 T DE8686301421 T DE 8686301421T DE 3687145 T DE3687145 T DE 3687145T DE 3687145 D1 DE3687145 D1 DE 3687145D1
Authority
DE
Germany
Prior art keywords
parts
mixture
zinc
calcium
balance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686301421T
Other languages
English (en)
Inventor
Charles Allen Jensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3687145D1 publication Critical patent/DE3687145D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
DE8686301421T 1986-01-27 1986-02-27 Anorganische mineralzusammensetzung. Expired - Lifetime DE3687145D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/822,532 US4810496A (en) 1985-02-19 1986-01-27 Treatment of skin and inflammatory disorders

Publications (1)

Publication Number Publication Date
DE3687145D1 true DE3687145D1 (de) 1992-12-24

Family

ID=25236296

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686301421T Expired - Lifetime DE3687145D1 (de) 1986-01-27 1986-02-27 Anorganische mineralzusammensetzung.

Country Status (5)

Country Link
US (1) US4810496A (de)
EP (1) EP0235417B1 (de)
AT (1) ATE82503T1 (de)
CA (1) CA1270196A (de)
DE (1) DE3687145D1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX168552B (es) * 1985-02-19 1993-05-31 Jensen Charles A Procedimiento para la preparacion de polvo mineral inorganico
US4931274A (en) * 1986-02-27 1990-06-05 Physiological Research Associates Composition for the effective treatment of scalp diseases that delivers magnesium adsorbed in alumina silicate clays to affected sites
US5061724A (en) * 1989-07-18 1991-10-29 Sheldon Gertner Method for treating arthritically inflamed body joints, particularly joints having gouty arthritis
US5435997A (en) * 1994-02-08 1995-07-25 Burns; Michael J. Topical agent and method for the treatment of pseudofolliculitis barbae
US5503822A (en) * 1994-04-01 1996-04-02 Schulman; Jerome M. Medicated gel
US5516517A (en) * 1994-05-02 1996-05-14 Exfoliation Cleansing Hydration Oxygenation Corporation Method for nutritional oxygenation of the skin
US5667790A (en) * 1995-08-14 1997-09-16 Sellers, Jr.; Billy B. Aluminum chlorhydrate as a treatment for acne and rosacea
US6565893B1 (en) 1999-02-17 2003-05-20 Worldwide Pure Water, Inc. Process for preparing a disinfectant containing suspended metals
US20030077301A1 (en) * 1999-12-16 2003-04-24 Maibach Howard I. Topical pharmaceutical composition for the treatment of inflammatory dermatoses
US20030072814A1 (en) * 1999-12-16 2003-04-17 Maibach Howard I. Topical pharmaceutical composition for the treatment of warts
EP1129715A1 (de) * 2000-02-25 2001-09-05 Werner Dr. Reichen Anwendung von Magnesium, Kalzium und Silizium zur Heilung verschiedener Krankheiten und zum allgemeinen Wohlbefinden
ES2279939T3 (es) * 2002-01-29 2007-09-01 Unilever N.V. Composiciones detergentes.
GB0202017D0 (en) * 2002-01-29 2002-03-13 Unilever Plc Detergent compositions
GB0228354D0 (en) * 2002-12-05 2003-01-08 Unilever Plc Detergent compositions
US6821523B2 (en) * 2002-06-21 2004-11-23 Dermatrends, Inc. Topical administration of pharmacologically active bases in the treatment of warts
US6846837B2 (en) * 2002-06-21 2005-01-25 Howard I. Maibach Topical administration of basic antifungal compositions to treat fungal infections of the nails
US6943197B2 (en) * 2002-06-21 2005-09-13 Howard I. Maibach Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses
KR20040031361A (ko) * 2002-10-04 2004-04-13 김고정 세포활성 및 독성제거제
US20040091417A1 (en) * 2002-11-07 2004-05-13 Nanoproducts Corporation Nanotechnology for agriculture, horticulture, and pet care
US7611732B2 (en) * 2004-07-26 2009-11-03 Michael Bentley Nutritional supplement for osteoarthritis
EP1627641A1 (de) * 2004-08-04 2006-02-22 Victor Eluwa Metalloxide enthaltende pharmazeutische Zusammensetzungen und deren Anwendungen
US7943617B2 (en) * 2006-11-27 2011-05-17 Bristol-Myers Squibb Company Heterobicyclic compounds useful as kinase inhibitors
GB0805279D0 (en) * 2008-03-20 2008-04-30 Univ Nottingham Trent Food supplement
FR2931359B1 (fr) * 2008-05-20 2012-12-21 Menvielle Bourg Fabienne Joanny Utilisation d'une matrice pour administration orale de magnesium a liberation prolongee, et composition contenant cette matrice
FR2931361B1 (fr) * 2008-05-20 2012-08-31 Menvielle Bourg Fabienne Joanny Systeme a base de magnesium et son utilisation en cosmetique
US20140234394A1 (en) * 2013-02-19 2014-08-21 William A. McDonough Benefical contact surfaces for functional objects

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3137622A (en) * 1957-12-23 1964-06-16 Kline Topical therapeutic composition
FR2336938A1 (fr) * 1976-01-02 1977-07-29 Sato Masataro Medicament a base de montmorillonite
JPS57156419A (en) * 1981-03-24 1982-09-27 Kyowa Chem Ind Co Ltd Remedy for sideropenia

Also Published As

Publication number Publication date
US4810496A (en) 1989-03-07
EP0235417A1 (de) 1987-09-09
ATE82503T1 (de) 1992-12-15
CA1270196A (en) 1990-06-12
EP0235417B1 (de) 1992-11-19

Similar Documents

Publication Publication Date Title
ATE82503T1 (de) Anorganische mineralzusammensetzung.
IL76119A (en) Device for initiating reperfusion treatment when heart attack symptoms are present
IE890343L (en) Ultrasonic contrast agents, process for their preparation and their use as diagnostic and therapeutic agents
EP0236684A3 (en) Galanthamine or analogues thereof for treating alzheimer's disease
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
JPS6480260A (en) Iron-calcium mineral supplied product having high biological utility
EP0430045A3 (en) Ascorbic acid tocopheryl phosphate diesters for inhibition of maillard's reaction
GB8604528D0 (en) Therapeutic agents
IL89807A (en) Topical preparation containing ofloxacin for treating otopathy
ZA904671B (en) Hair treatment composition
GB2177091B (en) 5,6-epoxy-7-oxabicycloheptane substituted amino prostaglandin analogs useful in the treatment of thrombotic disease
IE893230L (en) Hydrocarbon substituted pyrrolidinones
PT81933A (en) Process for preparing improved antiinflammatory compositions containing pyroxicam and inositol
JPS6481886A (en) Hydrous soil solidifying agent
EP0204954A3 (en) Use of dopamine agonists in the treatment of psychostimulant addiction
ZA86599B (en) Toothpaste
NZ220495A (en) A2a cyclopeptan-2-ones carrier containing methotrexate compositions
IT8419890A0 (it) Attrezzo per l'esercizio del corpodi impiego universale.
ATE77550T1 (de) Kontrolle der haem- und eisenkonzentrationen im koerpergewebe.
EP0458537A3 (en) Therapeutic compound for the treatment of bronchitis
AU6461590A (de)
PH24127A (en) Cycloalkane(1,2-c:4,3-c')dipyrazoles and their use as bronchodilators
EP0353910A3 (en) Human interferon-gamma, process for preparing said human interferon-gamma, and its use
Menninger The middle of the journey: Dragons and grails.
ZA849270B (en) Soporific containing lorazepam

Legal Events

Date Code Title Description
8332 No legal effect for de